E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/27/2006 in the Prospect News Biotech Daily.

Endologix files $50 million stock shelf

New York, April 27 - Endologix, Inc. registered to sell up to $50 million of common stock in an S-3 filing with the Securities and Exchange Commission.

The Irvine, Calif., maker of minimally invasive therapies for the treatment of cardiovascular disease said it will specify the use of proceeds at the time of sale.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.